Among the 40 WNT-activated medulloblastomas included in the present study, we successfully evaluated CTNNB1 mutations in 33 cases and found 73% (24/33) of CTNNB1-mutated cases and 27% (9/33) CTNNB1 wild type. The gene discussed is CTNNB1; the disease is medulloblastoma.